Product Information

JANUMET XR 50-500 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $5.2826 per EA under NDC 00006007861. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Feb 2, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

JANUMET XR 50-500 MG TABLET

sitagliptin and metformin hydrochloride
$5.2826per EA

Strength

500; 50 mg/1; mg/1

NDC

00006007861

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA202270

FDA Approved

2/2/2012

TE Code

AB

On Market Since

2/2/2012

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for JANUMET XR 50-500 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 27.6%. The table below summarizes its recorded NADAC range and movement.

Current price$5.2826 per EA
All-time high$9.1846 (Sep 11, 2024)
All-time low$4.1412 (Nov 28, 2013)
52-week high$5.2882
52-week low$5.2799
Median price$6.9029
Average price$6.8221
Largest weekly change-42.4% (Jan 1, 2025)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.0%

1M

+0.0%

3M

+0.0%

6M

-0.0%

1Y

+0.1%

3Y

-39.5%

5Y

-33.4%

All

+27.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of JANUMET XR 50-500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for JANUMET XR 50-500 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $5.2826 per EA (NDC 00006007861), effective Aug 19, 2026.

How has the price of JANUMET XR 50-500 MG TABLET changed over time?

Over the history we have for it, the NADAC for JANUMET XR 50-500 MG TABLET has risen 27.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for JANUMET XR 50-500 MG TABLET?

Since Nov 28, 2013, the NADAC for JANUMET XR 50-500 MG TABLET has ranged from a low of $4.1412 (Nov 28, 2013) to a high of $9.1846 (Sep 11, 2024), with a median of $6.9029 per EA.

Are there cheaper alternatives to JANUMET XR 50-500 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as JANUMET XR 50-500 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures JANUMET XR 50-500 MG TABLET?

JANUMET XR 50-500 MG TABLET (NDC 00006007861) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.